Market Research Reports - Ken Research Australia Drug Delivery Devices Market Outlook to

Westernization and Industrialization in Australia to boost Drug Delivery Devices Market: Ken
Research
Australia encouraged nanotechnology applications in various sectors such as energy, food,
water, drug delivery and new ways to regenerate damaged parts of a human body such as
blood vessels, brain, nerves, bone and cartilage. Nanotechnology is a thriving field for scientific
and technological creativity in areas such as nano-materials, nano- biotechnology, electronics
and photonics, energy and environment and quantum technology. Nanotechnology is used in
delivering medical solutions to prevent the transmission of sexually transmitted infections. A
combination of nanotechnology and ultrasound is used to replace injections with non-invasively
deliver of drugs.
According to the study “Australia Drug Delivery Devices Market Outlook to 2023-Central
Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler
Devices”, the various categories in Australian drug delivery devices are central venous
catheters, needle free injections, infusion systems and metered dose inhaler devices. The major
key companies operating within the Australia Drug Delivery Devices market are
GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer
Ingelheim GmbH, Baxter International Inc, Medtronic plc and others. All the new entrants in the
drug delivery devices market in Australia are faced with cut throat competition due to
innovative technology, quality services and diligence of international vendors.
There are various forms of drug delivery systems available in Australia for the treatment of
chronic obstructive pulmonary disorders (COPD). Respiratory inhalers and nebuliser are the
main forms of drug administration devices. Smart inhalers were developed with new age digital
technology to improve respiratory disease management. Smart inhalers are equipped with a
digital sensor that tracks the data of dosage timing, monitors the use of the inhaler, and
schedules the next dosage. The respiratory inhalers are used at hospitals, clinics, respiratory
care center, and other places. Nebulisers are categorised into Compressed air nebuliser,
Ultrasonic nebuliser, and Mesh nebuliser. Ultrasonic nebulizers comprise of better technology
compared to the jet nebulizers that are currently available. The leading vendors in respiratory
inhalers market are investing heavily in the development of different kinds of inhalers and
nebulizers that provide easy access to the patients. It was observed that the number of
Australian population suffering from asthma and COPD are increasing drastically. COPD is the
third deadly disease and can be controlled while creating awareness among the population
coupled with development of new drugs.
The increasing prevalence of chronic diseases in Australia such as cancer, CVDs, hormonal
disorders, and other diseases has encouraged infusion systems for medical treatment. The
emerging trends in infusion systems market are encouraging the adoption of power-driven and